<img alt="" src="https://secure.52enterprisingdetails.com/787780.png" style="display:none;">
Skip to content

Biostatistics

Whether you need help with calculating sample size, or you need support with designing your clinical study or clinical investigation from start to finish, we can provide custom solutions for ensuring high-quality data analysis.

The biostatistics team plays a vital role in planning the clinical trial design, sample size, randomization procedures, and statistical analysis. Thus, the biostatistician’s expertise is pivotal in ensuring a robust data analysis and making sure that the clinical study/investigation has sufficient power to answer the primary objective.

Biostatisticians are also crucial in interpreting the data, drawing conclusions, and handling statistical issues such as multiplicity. The biostatistics team documents the statistical methods in the Statistical Analysis Plan (SAP), which describes the analyses in detail including subgroup analyses, how missing data is handled, and how the data will be presented in the final study/investigation report.

Our biostatistics services include:

  • Clinical trial design planning and sample size calculations
  • Development of the Statistical Analysis Plan (SAP) according to the study/investigation protocol
  • Randomization procedures
  • Statistical programming for the final analysis, as well as reports for interim analyses, risk-based monitoring, data monitoring committees, and regulatory submissions.
  • Biostatistical analysis including all tables, figures and analyses according to the SAP.
  • Support with data interpretation and development of the final report and/or interim reports

Contact us for more information

Ulrika Heldestad
Ulrika Heldestad
BD & Sales Director

Leave a contact request

Latest news

Notice about a change in some of our email addresses

As part of the upcoming company split on 1 January 2026, some of our email domains will change to @labquality.com...

How do you shape regulatory complexity into strategic clarity?

As AI continues to reshape healthcare, clear guidance on health data use is more critical than ever. Building on the...

Fast track for mononational clinical trial applications in Sweden

Starting September 1, 2025, the Swedish Medical Products Agency (Läkemedelsverket) introduced a fast-track process for...

Upcoming webinar: what IVDR Article 5(5) means for your lab

Whether your lab is already working under IVDR and Article 5(5), evaluating tests, or preparing for transition, this...

IVDR reality check: are we moving fast enough?

As of February 2025, approximately 1,500 IVDR certificates have been issued. That’s progress — but is it enough? With...